Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Zimmer Biomet Inc.

    NYSE: ZBH · Real-Time Price · USD
    92.13
    0.85 (0.93%)
    At close: Jun 16, 2025, 3:59 PM
    92.75
    0.68%
    After-hours: Jun 16, 2025, 07:29 PM EDT

    Zimmer Biomet Statistics

    Share Statistics

    Zimmer Biomet has 197.85M shares outstanding. The number of shares has increased by -3.24% in one year.

    Shares Outstanding

    n/a
    		 197.85M

    Shares Change (YoY)

    n/a
    		 -3.24%

    Shares Change (QoQ)

    n/a
    		 -0.01%

    Owned by Institutions (%)

    n/a
    		 90.01%

    Shares Floating

    n/a
    		 197.57M

    Failed to Deliver (FTD) Shares

    n/a
    		 144

    FTD / Avg. Volume

    n/a
    		 0.01%

    Short Selling Information

    The latest short interest is 5.51M, so 2.79% of the outstanding shares have been sold short.

    Short Interest

    n/a
    		 5.51M

    Short % of Shares Out

    n/a
    		 2.79%

    Short % of Float

    n/a
    		 3.19%

    Short Ratio (days to cover)

    n/a
    		 2.07

    Valuation Ratios

    The PE ratio is 23.74 and the forward PE ratio is 10.97. Zimmer Biomet's PEG ratio is -2.53.

    PE Ratio

    n/a
    		 23.74

    Forward PE

    n/a
    		 10.97

    PS Ratio

    n/a
    		 2.79

    Forward PS

    n/a
    		 1.8

    PB Ratio

    n/a
    		 1.72

    P/FCF Ratio

    n/a
    		 18.78

    PEG Ratio

    n/a
    		 -2.53
    Financial Ratio History

    Enterprise Valuation

    Zimmer Biomet has an Enterprise Value (EV) of 27.13B.

    EV / Sales

    n/a
    		 3.53

    EV / EBITDA

    n/a
    		 12.05

    EV / EBIT

    n/a
    		 18.1

    EV / FCF

    n/a
    		 23.75

    Financial Position

    The company has a current ratio of 1.91, with a Debt / Equity ratio of 0.5.

    Current Ratio

    n/a
    		 1.91

    Quick Ratio

    n/a
    		 0.99

    Debt / Equity

    n/a
    		 0.5

    Debt / EBITDA

    n/a
    		 2.76

    Debt / FCF

    n/a
    		 5.43

    Interest Coverage

    n/a
    		 5.9

    Financial Efficiency

    Return on Equity is 7.25% and Return on Invested Capital is 5.68%.

    Return on Equity

    n/a
    		 7.25%

    Return on Assets

    n/a
    		 4.23%

    Return on Invested Capital

    n/a
    		 5.68%

    Revenue Per Employee

    n/a
    		 $451,682.35

    Profits Per Employee

    n/a
    		 $53,164.71

    Employee Count

    n/a
    		 17,000

    Asset Turnover

    n/a
    		 0.36

    Inventory Turnover

    n/a
    		 0.98

    Taxes

    Income Tax

    n/a
    		 131.4M

    Effective Tax Rate

    n/a
    		 12.68%

    Stock Price Statistics

    The stock price has increased by -13.93% in the last 52 weeks. The beta is 0.72, so Zimmer Biomet's price volatility has been higher than the market average.

    Beta

    n/a
    		 0.72

    52-Week Price Change

    n/a
    		 -13.93%

    50-Day Moving Average

    n/a
    		 96.69

    200-Day Moving Average

    n/a
    		 104.73

    Relative Strength Index (RSI)

    n/a
    		 43.45

    Average Volume (20 Days)

    n/a
    		 2,258,179

    Income Statement

    In the last 12 months, Zimmer Biomet had revenue of 7.68B and earned 903.8M in profits. Earnings per share was 4.45.

    Revenue

    n/a
    		 7.68B

    Gross Profit

    n/a
    		 5.49B

    Operating Income

    n/a
    		 1.29B

    Net Income

    n/a
    		 903.8M

    EBITDA

    n/a
    		 2.25B

    EBIT

    n/a
    		 1.25B

    Earnings Per Share (EPS)

    n/a
    		 4.45
    Full Income Statement

    Balance Sheet

    The company has 525.5M in cash and 6.2B in debt, giving a net cash position of -5.68B.

    Cash & Cash Equivalents

    n/a
    		 525.5M

    Total Debt

    n/a
    		 6.2B

    Net Cash

    n/a
    		 -5.68B

    Retained Earnings

    n/a
    		 11.1B

    Total Assets

    n/a
    		 22.18B

    Working Capital

    n/a
    		 3.3B
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was 1.5B and capital expenditures -356.8M, giving a free cash flow of 1.14B.

    Operating Cash Flow

    n/a
    		 1.5B

    Capital Expenditures

    n/a
    		 -356.8M

    Free Cash Flow

    n/a
    		 1.14B

    FCF Per Share

    n/a
    		 5.63
    Full Cash Flow Statement

    Margins

    Gross margin is 71.46%, with operating and profit margins of 16.74% and 11.77%.

    Gross Margin

    n/a
    		 71.46%

    Operating Margin

    n/a
    		 16.74%

    Pretax Margin

    n/a
    		 13.5%

    Profit Margin

    n/a
    		 11.77%

    EBITDA Margin

    n/a
    		 29.31%

    EBIT Margin

    n/a
    		 16.74%

    FCF Margin

    n/a
    		 14.88%

    Dividends & Yields

    ZBH pays an annual dividend of $1.2, which amounts to a dividend yield of 1.05%.

    Dividend Per Share

    n/a
    		 $1.20

    Dividend Yield

    n/a
    		 1.05%

    Dividend Growth (YoY)

    n/a
    		 0%

    Payout Ratio

    n/a
    		 26.67%

    Earnings Yield

    n/a
    		 4.21%

    FCF Yield

    n/a
    		 5.33%
    Dividend Details

    Analyst Forecast

    The average price target for ZBH is $112, which is 21.6% higher than the current price. The consensus rating is "Hold".

    Price Target

    n/a
    		 $112

    Price Target Difference

    n/a
    		 21.6%

    Analyst Consensus

    n/a
    		 Hold

    Analyst Count

    n/a
    		 21
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 n/a

    Lynch Upside

    n/a
    		 n/a

    Graham Number

    n/a
    		 78.4

    Graham Upside

    n/a
    		 -14.89%

    Stock Splits

    The last stock split was on Mar 1, 2022. It was a forward split with a ratio of 103:100.

    Last Split Date

    n/a
    		 Mar 1, 2022

    Split Type

    n/a
    		 forward

    Split Ratio

    n/a
    		 103:100

    Scores

    Altman Z-Score

    n/a
    		 2.56

    Piotroski F-Score

    n/a
    		 7

    Add to Watchlist